City of Hope began CIRM-funded Coronavirus study
On Apr. 30, 2020, The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hopeﾒs John…
Vaxart announced additional positive pre-clinical data for oral COVID-19 vaccine program
On Apr. 30, 2020, Vaxart announced it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
On Apr. 30, 2020, Eiger BioPharmaceuticals announced that the first patients have been dosed in a Phase 2…
Tyson Foods partnered with Matrix Medical Network to provide on-site healthcare services
On Apr. 30, 2020, Tyson announced a partnership with Matrix Medical Network to help ensure the safety and…
INOVIO expanded manufacturing of COVID-19 DNA vaccine INO-4800 with new funding from CEPI
On Apr. 30, 2020, INOVIO announced an agreement to expand its manufacturing partnership with the German contract manufacturer…
The US Dept. of Veterans Affairs joined XPRIZE Pandemic Alliance to combat COVID-19 and future outbreaks
On Apr. 29, 2020, the U.S. Dep. of Veterans Affairs (VA) announced a partnership with the XPRIZE Foundationﾒs…
NIH mobilized national innovation RADx initiative for COVID-19 diagnostics
On Apr. 29, 2020, the NIH announced a new initiative aimed at speeding innovation, development and commercialization of…
Gilead announced results from phase 3 trial of investigational antiviral Remdesivir in patients with severe COVID-19
On Apr. 29, 2020, Gilead announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and…
Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
Hologic to introduce second high-throughput molecular assay for novel Coronavirus (SARS-CoV-2)
On Apr. 29, 2020, Hologic announced that it planned to launch a new Aptimaﾮ molecular assay to detect…
University of Nebraska Medical Center remdesivir clinical trial show accelerated recovery from advanced COVID-19
On Apr. 29, 2020, hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than…
Catalent signs agreement with Johnson & Johnson to be US manufacturing partner for lead COVID-19 vaccine candidate
On Apr. 29, 2020, Catalent announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby…
Chimerix announced initiation of phase 2/3 study of DSTAT in acute lung injury for patients with severe COVID-19
On Apr. 29, 2020, Chimerix announced initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19…
OPKO Health’s BioReference Laboratories partnership with New York State initiated testing for COVID-19 antibodies
On Apr. 29, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19…
Windtree announced first patient enrolled in AEROSURF bridging study for treatment of Respiratory Distress Syndrome
On Apr. 29, 2020, Windtree Therapeutics announced it has enrolled the first patient into its AEROSURF phase 2b…
NIH mobilized national innovation initiative for COVID-19 diagnostics
On Apr. 29, 2020, the NIH announced a new $1.5 billion federal stimulus funding initiative aimed to speed…
Quest Diagnostics launched consumer-Initiated COVID-19 antibody test through QuestDirectﾙ
On Apr. 28, 2020, Quest Diagnostics announced that individuals can purchase COVID-19 antibody testing for themselves online, without…
Chimerix received FDA clearance for rolling submission of New Drug Application for brincidofovir as medical countermeasure for smallpox
On Apr. 28, 2020, Chimerix announced it had received clearance from the FDA for a rolling submission of…
INOVIO completed enrollment in phase 1 U.S. trial of INO-4800 for COVID-19 DNA vaccine
On Apr. 28, 2020, INOVIO announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800…
Meridian Bioscience simplified COVID-19 sample prep and eliminated dependence on reagents in short supply
On Apr. 27, 2020, Meridian Bioscience announced the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step…
Aegis Sciences doubled capacity for Coronavirus disease 2019 (COVID-19) testing
On Apr. 27, 2020, Aegis Sciences announced expanded capacity to incrementally ramp up to 7,000 tests per day…
Diffusion Pharma announced pre-IND submission to FDA of design for TSC trials to treat Acute Respiratory Distress Syndrome in COVID-19
On Apr. 27, 2020, Diffusion Pharmaceuticals announced the pre-IND submission to the FDA of a planned clinical program…
Abbottr received Health Canada Authorization under Interim Order to use FreeStyleﾮ Libre System for hospitalized patients during COVID-19 pandemic
On Apr. 27, 2020, Abbott announced that Health Canada authorized use of FreeStyle Libre system, a sensor-based glucose…
Tgen began recruiting volunteer patients for COVID-19 immunity study
On Apr. 27, 2020, TGen, an affiliate of City of Hope is looking for volunteers: individuals who have…
ARTES joined global combat against Corona with virus-like particle based platform technologies
On Apr. 27, 2020, ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered…
LabCorp COVID-19 antibody tests available nationwide with no upfront out-of-pocket costs
On Apr. 27, 2020, LabCorpﾮ announced that it will offer antibody tests for the virus that causes COVID-19….
Potential new HIV treatment developed at University of Nebraska Medical Center
On Apr. 27, 2020, a novel means to prevent HIV infection was developed at the University of Nebraska…
Oxford University researchers used virus genomic tracking to reveal the rise and fall of the COVID-19 epidemic in Guangdong Province
On Apr. 24, 2020, a new study led by researchers at Oxford and Guangdong Centre for Diseases Control…
Johnson & Johnson announced collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate
On Apr. 23, 2020, Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical of Johnson & Johnson…
Brensocatib (formerly INS1007) to be studied in patients with severe COVID-19 in investigator-initiated trial
On Apr. 23, 2020, Insmed announced that it will provide funding and clinical drug supply for the STOP-COVID19…